Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

NCT03349840 is registered in ClinicalTrials.gov with Weill Cornell Medical College in Qatar as lead sponsor.

NCT NCT03349840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03349840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan
Lead sponsor
Weill Cornell Medical College in Qatar
Phase
Phase 4
Overall status
Terminated
Start date
January 7, 2018
Completion date
December 31, 2018
Enrollment
273 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes